Exelixis (EXEL) Share-based Compensation (2010 - 2026)

Exelixis (EXEL) recorded quarterly Share-based Compensation of $29.0 million in Q2 2026, up 44.55% quarter-over-quarter from $20.1 million in Q1 2026, and up 12.03% on a YoY basis from $25.9 million in Q2 2025.

Exelixis (EXEL) Share-based Compensation (2010 - 2026) Analysis & Trends

Exelixis' Share-based Compensation history runs 17 years deep, the most recent figure standing at $29.0 million for Q2 2026.

  • In Q2 2026, Share-based Compensation rose 12.03% year-over-year to $29.0 million; the TTM figure through Apr 2026 stood at $116.1 million (up 15.35% YoY), while the FY2026 annual figure was $113.0 million, up 20.4% from the prior year.
  • Share-based Compensation was $29.0 million for Q2 2026 at Exelixis, up from $20.1 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $40.5 million in Q3 2023 to a low of $16.7 million in Q1 2023.
  • Historically, Share-based Compensation has averaged $26.5 million across 5 years, with a median of $25.4 million in 2024.
  • The sharpest annual moves came in 2024 and 2025: Share-based Compensation slumped 43.12% in 2024, then jumped 42.27% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $25.9 million in 2022, then slipped by 5.99% to $24.3 million in 2023, then fell by 5.28% to $23.0 million in 2024, then jumped by 34.15% to $30.9 million in 2025, then retreated by 5.94% to $29.0 million in 2026.
  • The last three Share-based Compensation figures came in at $29.0 million (Q2 2026), $20.1 million (Q1 2026), and $30.9 million (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - 305,000.00
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 166.40 Mn
9 Abivax 95.45 Bn 95.45 Bn - 26.47 Mn
10 Exelixis 13.71 Bn 12.93 Bn 590.86 Mn 29.05 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 29.05 Mn
Apr 3, 2026 29.05 Mn
Jan 2, 2026 20.10 Mn
Jan 2, 2026 20.10 Mn
Oct 3, 2025 30.89 Mn
Oct 3, 2025 30.89 Mn
Jul 4, 2025 36.07 Mn
Jul 4, 2025 36.07 Mn
Apr 4, 2025 25.93 Mn
Apr 4, 2025 25.93 Mn
Jan 3, 2025 26.35 Mn
Jan 3, 2025 26.35 Mn
Sep 27, 2024 23.02 Mn
Sep 27, 2024 23.02 Mn
Jun 28, 2024 25.35 Mn
Jun 28, 2024 25.35 Mn
Mar 29, 2024 19.11 Mn
Mar 29, 2024 19.11 Mn
Dec 29, 2023 24.31 Mn
Dec 29, 2023 24.31 Mn